Deep learning-based multimodal model for predicting on-treatment histological outcomes in chronic hepatitis B-associated advanced liver fibrosis

Figure 5 Saliency map. A: Predicted non-reversal hematoxylin and eosin image (left), its corresponding saliency map (center), and the overlaid composite image (right). Darker red regions indicate more prominent features associated with non-reversal; B: Predicted non-reversal Masson-stained image (left), its corresponding saliency map (center), and the overlaid composite image (right). Darker red regions indicate more prominent features associated with non-reversal. HE: Hematoxylin and eosin.